Performant Financial (PFMT) Q3 2024 earnings summary

Executive summary

• Healthcare revenues rose 6% year-over-year to $30.3 million, with total Q3 2024 revenues up 5% to $31.5 million; net loss widened to $2.4 million from $0.6 million year-over-year.

• Adjusted EBITDA for Q3 2024 was $2 million, flat year-over-year, with claims-based services up 38% and eligibility-based services down 12%.

• Strategic focus shifted entirely to healthcare payment integrity, reducing exposure to volatile customer care services.

• Expanded into the state Medicaid market with a significant New York State Recovery Audit contract win, expected to start in Q2 2025.

• Growth was primarily attributed to ongoing commercial implementations and expanded CMS RAC Region 2 contract scope.

Financial highlights

• Q3 2024 total revenues were $31.5 million, with healthcare revenues at $30.3 million (6% year-over-year growth).

• Net loss for Q3 2024 was $2.4 million, up from $0.6 million in Q3 2023; adjusted EBITDA was $1.9–$2 million, flat year-over-year.

• Claims-based business revenue grew over 30% year-over-year, reaching $14.2 million in Q3; eligibility revenues were $16.1 million, down 12% year-over-year.

• Customer care/outsourced services revenue declined to $1.2 million, with further reductions expected.

• Operating expenses increased to $33.7 million from $30.6 million year-over-year, driven by scaling, IT investments, and sales team expansion.

Outlook and guidance

• 2024 healthcare revenue guidance reiterated at $117–$122 million and Adjusted EBITDA at $4–$5 million.

• New York State RAC contract expected to reach double-digit millions in annual revenue at steady state, with a typical 2–3 year ramp.

• Margin profile for new Medicaid contracts expected to be similar to existing government and commercial business.

• Margin expansion from RecordsOne integration anticipated to begin in 2025, with more significant impact in 2026–2027.

• Management remains confident in meeting guidance despite challenging healthcare market conditions.